The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quality-adjusted survival in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC) receiving first-line therapy with panitumumab plus FOLFOX versus FOLFOX alone in the PRIME trial.
 
Jianmin Wang
Research Funding - Amgen (Inst)
 
Jun Dong
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Patrick Johnson
Employment - Amgen
Stock and Other Ownership Interests - Pfizer
 
Gregory A. Maglinte
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Alan Rong
Employment - Amgen; Amgen (I)
Stock and Other Ownership Interests - Amgen; Amgen (I)
 
Beth L. Barber
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Jean-Yves Douillard
Honoraria - Amgen; Bayer; Merck; Roche
Consulting or Advisory Role - Amgen; Bayer; Merck; Roche
Research Funding - Merck Serono (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Merck; Roche